The benefits of using piezofilm detection technology at the point-of-care are described on a new website launched by Vivacta.
With the help of informative graphics, the website provides a concise introduction into how this technology enables the creation of fast, simple and accurate immunoassay-based near-patient diagnostic tests.
The website also reviews the benefits of basing critical diagnostic measurements on an electrical output as opposed to the current optical methods of signal detection, such as photometric, fluorescence and chemiluminescence.
An illustration is also provided, showing the simple sequence that leads from taking a 30um whole blood sample, using Vivacta's disposable cartridge, right through to final result generation on the portable reader.
Via a link to a published paper, the performance details of Vivacta's lead assay - a highly sensitive test for TSH - can be accessed from the website.
This serves to give an example of the performance conferred by the company's piezofilm technology.
